Results
145
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
145 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NB | US$2.38 | -8.8% | -3.6% | US$109.1m | US$3.63 | PB16.2x | S64.4% | n/a | ||
ALB New | US$83.58 | 10.4% | -27.2% | US$9.5b | US$102.24 | PS1.8x | E56.9% | 1.9% | ||
NEU | US$559.55 | 4.8% | -8.1% | US$5.2b | n/a | PE11.6x | n/a | 1.8% | ||
FMC | US$38.01 | 4.3% | -25.5% | US$4.6b | US$51.95 | PE11.8x | E10.2% | 6.1% | ||
USGO | US$11.90 | -5.5% | 103.1% | US$144.4m | US$26.50 | PB12.1x | n/a | n/a | ||
RYI | US$22.96 | -0.9% | -33.2% | US$699.4m | US$23.00 | PE34x | S0.5% | 3.3% | ||
ABAT | US$1.26 | 3.3% | -35.7% | US$116.8m | n/a | PS121.5x | n/a | n/a | ||
PTVE | US$17.82 | 0.4% | 22.6% | US$3.2b | US$16.80 | PS0.6x | E86.6% | 2.2% | ||
AA | US$37.01 | -0.4% | 38.7% | US$9.4b | US$48.04 | PE170.7x | E21.4% | 1.1% | ||
VRDR | US$0.15 | -1.0% | 21.6% | US$219.8m | n/a | PS875.7x | n/a | n/a | ||
ALTM | US$5.83 | 1.7% | 25.4% | US$5.5b | US$6.09 | PE35.7x | E30.6% | n/a | ||
VITF.F | US$0.35 | 0% | -91.3% | US$23.4m | n/a | PE2.1x | S-123.7% | n/a | ||
EXP | US$250.52 | -1.8% | 3.5% | US$8.4b | US$289.80 | PE17.6x | E8.6% | 0.4% | ||
PPG | US$119.26 | 3.8% | -15.5% | US$27.3b | US$134.05 | PE20.6x | E9.4% | 2.3% | ||
PCT | US$10.90 | 24.4% | 85.1% | US$1.7b | US$13.10 | PB8x | E57.7% | n/a | ||
IP | US$57.28 | 2.9% | 60.3% | US$29.6b | US$56.95 | PE54.2x | E22.7% | 3.2% | ||
LYB | US$78.22 | 2.4% | -18.7% | US$24.9b | US$86.20 | PE18.7x | E21.6% | 6.9% | ||
IFF | US$86.45 | 1.5% | 5.4% | US$21.9b | US$104.01 | PS1.9x | E71.2% | 1.9% | ||
CRH | US$110.51 | 7.3% | 42.4% | US$73.3b | US$114.28 | PE21.6x | E9.5% | 1.3% | ||
SCL | US$62.49 | -0.4% | -31.3% | US$1.4b | US$90.00 | PE30.7x | E53.9% | 2.5% | ||
PRML.F New | US$0.24 | -5.8% | -75.7% | US$51.7m | US$2.35 | PB8.4x | S30.6% | n/a | ||
ARQ | US$5.67 | -1.0% | 64.3% | US$248.4m | US$9.50 | PS2.2x | E51.3% | n/a | ||
LOMA | US$11.82 | 4.7% | 84.7% | US$1.4b | US$12.08 | PE20.5x | E14.2% | 1.2% | ||
FRD | US$16.87 | -1.8% | -2.5% | US$122.0m | n/a | PE20.8x | n/a | 0.9% |